PATH-60. AUTOMATED QUANTIFICATION OF KI-67 PROLIFERATION INDEX BASED ON WHOLE SLIDE IMAGES IN PEDIATRIC BRAIN TUMORS

Abstract The use of AI methods with histopathological images (pathomics) has strong potential to aid pathologists in pediatric brain cancer diagnosis and prognosis given the morphological and molecular heterogeneity of these tumors. However, use of pathomics in this context has been relatively limited. One example is the IHC-based tumor proliferation index (percentage of Ki-67 positive cells amongst all malignant cells) which is often routinely reviewed by pathologists clinically but remains to be objectively quantified or reported in a standardized manner. As a result, analysis of this marker across patients at-scale and in data-driven methods remains largely hindered. Here, we explore the extension of an automated deep learning AI tool (DeepLIIF), originally trained and validated with adult breast/prostate/liver data, for quantification of Ki-67 index from digitized whole slide images of a cohort of pediatric brain tumors from the Children’s Brain Tumor Network (N=834). We find that derived Ki-67 scores largely agreed with neuropathologist-reported Ki-67 activity in original clinical notes and could be used to successfully stratify glioma/astrocytoma patients (N=200) into low- and high-grade groups (LGG: M=11.6; SEM=1.2; HGG: M=18.7; SEM=2; p=0.001). Ki-67 scores were also related to the survival status of the patients (Alive: M=11.8; SEM=1.1; Deceased: M=18.8; SEM=2.2; p=0.003). Summary statistics across tumor types (glioma, astrocytoma, medulloblastoma, ATRT, ependymoma, etc.) and molecularly defined subtypes are also compared, providing direct insights into distributional properties between these groups that has not previously been feasible. Our results show the ability of AI-powered methods to quantify routine histopathology metrics with little human input, allowing objective comparisons between patients and opening the door for precision medicine approaches with predictive analytics in clinical contexts.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2024-11-01
DOI
https://doi.org/10.1093/neuonc/noae165.0759
Primary Topic
Medical Imaging Techniques and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PATH-60. AUTOMATED QUANTIFICATION OF KI-67 PROLIFERATION INDEX BASED ON WHOLE SLIDE IMAGES IN PEDIATRIC BRAIN TUMORS

Anahita Fathi Kazerooni, Ariana Familiar, Adam Kraya, Angela N. Viaene et al.
Neuro-Oncology
Medical Imaging Techniques and Applications
article

PATH-60. AUTOMATED QUANTIFICATION OF KI-67 PROLIFERATION INDEX BASED ON WHOLE SLIDE IMAGES IN PEDIATRIC BRAIN TUMORS

Anahita Fathi Kazerooni, Ariana Familiar, Adam Kraya, Angela N. Viaene, Derek A. Oldridge, Phillip B. Storm, Ali Nabavizadeh, Meen Chul Kim, Adam Resnick
article en

Abstract

Abstract The use of AI methods with histopathological images (pathomics) has strong potential to aid pathologists in pediatric brain cancer diagnosis and prognosis given the morphological and molecular heterogeneity of these tumors. However, use of pathomics in this context has been relatively limited. One example is the IHC-based tumor proliferation index (percentage of Ki-67 positive cells amongst all malignant cells) which is often routinely reviewed by pathologists clinically but remains to be objectively quantified or reported in a standardized manner. As a result, analysis of this marker across patients at-scale and in data-driven methods remains largely hindered. Here, we explore the extension of an automated deep learning AI tool (DeepLIIF), originally trained and validated with adult breast/prostate/liver data, for quantification of Ki-67 index from digitized whole slide images of a cohort of pediatric brain tumors from the Children’s Brain Tumor Network (N=834). We find that derived Ki-67 scores largely agreed with neuropathologist-reported Ki-67 activity in original clinical notes and could be used to successfully stratify glioma/astrocytoma patients (N=200) into low- and high-grade groups (LGG: M=11.6; SEM=1.2; HGG: M=18.7; SEM=2; p=0.001). Ki-67 scores were also related to the survival status of the patients (Alive: M=11.8; SEM=1.1; Deceased: M=18.8; SEM=2.2; p=0.003). Summary statistics across tumor types (glioma, astrocytoma, medulloblastoma, ATRT, ependymoma, etc.) and molecularly defined subtypes are also compared, providing direct insights into distributional properties between these groups that has not previously been feasible. Our results show the ability of AI-powered methods to quantify routine histopathology metrics with little human input, allowing objective comparisons between patients and opening the door for precision medicine approaches with predictive analytics in clinical contexts.

Neuro-OncologyVol. 26(Supplement_8)
Children's Hospital of Philadelphia (US), Hospital of the University of Pennsylvania (US)
Good health and well-being
Openalex Percentile: Top 67%
Medical Imaging Techniques and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.